Literature DB >> 23386491

S-1-induced lung injury combined with pneumocystis pneumonia.

Shuichi Yano1.   

Abstract

Pulmonary injuries due to S-1 have been reported, and these reports have shown an increase in lung cancer following the increased usage of S-1 in treating lung cancer. We report the first case of lung injury due to S-1 in combination with pneumocystis pneumonia (PCP), because the radiological findings and clinical courses were compatible with S-1-induced lung injury combined with PCP. We should consider that S-1 might induce lung injuries which might occur with PCP, especially with a history of drug-induced or radiation-induced lung injuries.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386491      PMCID: PMC3604487          DOI: 10.1136/bcr-2012-008171

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.

Authors:  R Trisolini; L Lazzari Agli; D Tassinari; D Rondelli; A Cancellieri; M Patelli; F Falcone; V Poletti
Journal:  Eur Respir J       Date:  2001-07       Impact factor: 16.671

Review 2.  Drug-induced and iatrogenic infiltrative lung disease.

Authors:  Philippe Camus; Philippe Bonniaud; Annlyse Fanton; Clio Camus; Nicolas Baudaun; Pascal Foucher
Journal:  Clin Chest Med       Date:  2004-09       Impact factor: 2.878

Review 3.  Treatment of acute lung injury: historical perspective and potential future therapies.

Authors:  Joseph E Levitt; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2006-08       Impact factor: 3.119

4.  Pulmonary toxicity by a cytotoxic agent, S-1.

Authors:  Yuji Tada; Yuichi Takiguchi; Ayako Fujikawa; Atsushi Kitamura; Katsushi Kurosu; Kenzo Hiroshima; Seiichiro Sakao; Yasunori Kasahara; Nobuhiro Tanabe; Koichiro Tatsumi; Takayuki Kuriyama
Journal:  Intern Med       Date:  2007-08-02       Impact factor: 1.271

5.  Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study.

Authors:  Sadatomo Tasaka; Hitoshi Tokuda; Fumikazu Sakai; Takeshi Fujii; Kazuhiro Tateda; Takeshi Johkoh; Norio Ohmagari; Hiromitsu Ohta; Hideki Araoka; Yoshimi Kikuchi; Masahide Yasui; Kanako Inuzuka; Hajime Goto
Journal:  Intern Med       Date:  2010-02-15       Impact factor: 1.271

6.  [DLST as a method for detecting TS-1-induced allergy].

Authors:  Rumi Kawabata; Masahiro Koida; Shohei Kanie; Gotaro Tanaka; Akinobu Ohuchida; Takemi Yoshida
Journal:  Gan To Kagaku Ryoho       Date:  2006-03

Review 7.  Pathologic characteristics of drug-induced lung disease.

Authors:  Douglas B Flieder; William D Travis
Journal:  Clin Chest Med       Date:  2004-03       Impact factor: 2.878

8.  Serum indicators for the diagnosis of pneumocystis pneumonia.

Authors:  Sadatomo Tasaka; Naoki Hasegawa; Seiki Kobayashi; Wakako Yamada; Tomoyasu Nishimura; Tsutomu Takeuchi; Akitoshi Ishizaka
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

  8 in total
  1 in total

1.  Drug-induced Pneumonitis Following the Administration of TAS-102.

Authors:  Yoshikazu Hasegawa; Takayo Ota; Hiroshi Tsukuda; Tomohiro Suzumura; Masahiro Fukuoka
Journal:  Intern Med       Date:  2016-10-01       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.